Anzeige
Mehr »
Login
Montag, 05.12.2022 Börsentäglich über 12.000 News von 678 internationalen Medien
Vor Ver-10-fachung? Jetzt schon in den Lithium-Star 2023 investieren?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrCatalent Completes Expansion of Clinical Supply Facility in Shanghai
FrCordenPharma Joins Science Based Targets Initiative
FrReaction Biology Acquires Bioassay GmbH and PSL
DoPrince Sterilization Services Receives NJMEP Manufacturer of the Year Award
DoAbCellera, Rallybio Enter Strategic Antibody Alliance for Rare Diseases
DoCharles River Launches Endosafe Nexus 200
DoFaron Names Dr. Maija Hollmén as Chief Scientific Officer
DoFerring\'s First-in-Class Microbiota-Based Live Biotherapeutic Approved
DoFerring Wins FDA Approval of First-in-Class Microbiota-Based Live Biotherapeutic
DoBioVaxys Successfully Completes Sterile Test-Run for Ovarian Cancer Vax
DoRoivant Sciences, Pfizer Form Vant to Develop & Commercialize RVT-3101
DoAugust Bioservices Secures $65M in Funding to Expand Capacity
MiWuXi STA Launches New Parenteral Formulation Manufacturing Line
MiRecipharm Invests in Single Dose Nasal Platform Capabilities
MiFrontage Central Labs Awarded CAP Accreditation
MiIncannex Engages Eurofins to Manufacture Topical Therapeutic ReneCann
MiBioNTech and Ryvu Therapeutics Enter Multi-Target Research Collaboration
MiExperic Closes $14 Million Series B Capitalization
DiAvectas Expands Collaboration with CCRM and OmniaBio Inc.
DiAndelyn Biosciences to Bring First Gene Therapy for Treatment of INAD to Clinical Trials
DiQuotient Sciences Partners with Emplicure to Manufacture and Study EMPLI03
DiAstraZeneca to Acquire Neogene Therapeutics in $320M Deal
DiBiocon Completes Acquisition of Viatris\' Global Biosimilars Business
DiBigHat Biosciences, Merck Enter AI Research Collaboration
DiImmutep Enters Clinical Trial Collaboration Merck KGaA and Pfizer